Stephen M. Schleicher, MD, MBA, Tennessee Oncology, co-authored a recent paper on the complexities of the rural cancer experience; the principal conclusion was potential for a streamlined care process to optimize care efficiencies and access, thereby improving patient outcomes.
1. In this cross-sectional study with 669 individuals, a 3-dimensional endophenotype was identified to elucidate the neuroanatomical, clinical and genetic heterogeneity of autism spectrum disorder. 2. There are partially overlapping neuroimaging and genetic signatures between individuals with autism spectrum disorder, schizophrenia and the general population. Evidence Rating Level: 2 (Good) Study Rundown: Autism Spectrum Disorder
Three-dimensional (3D) host architectures have emerged as promising strategies for resolving the critical issues of Li metal anodes, namely, severe volume changes and growth of Li dendrites during battery cycling. However, preferential Li plating on top of the host architecture often causes early cell failure. Herein, we demonstrate that the controlled heterogeneity of interfacial activity and the porous structure at the electrode level enables confined Li metal storage in host architectures consisting of metal-organic framework (MOF)-derived carbon. 3D electrochemical simulations show that carbon activity (lithiophilicity) and interparticle porosity play critical roles in controlling the competing kinetics of charge transfer and Li+ transport, thereby regulating the Li-plating behavior. The enhanced lithiophilicity at the electrode bottom, combined with the increased interparticle porosity at the top, is predicted to promote the preferential nucleation of Li and subsequent upward grow
the flu and rrsv, what people should be thinking about as they go into the holidays. with covid-19, the numbers are starting to trend up again, so the hospitalizations are up about 25%. the positivity is up around 25%. there s heterogeneity across the country. the most important message is get your new bivalent booster. and the reason you have to get it is two reasons. once you re four or five months out of your previous booster, your risk of hospitalization goes up. there s this buzz out there that says, oh you don t really need to get the booster because it s only we re not stopping infection anyway, no, the booster is keeping people ouch the hospital. more than four or five months, you need to get a booster anyway. you need to get the bivalent booster. i don t think you have that one. the dominant circulating